News
-
PSA voting record
Monday | May 15 2017THE Pharmaceutical Society of Australia (PSA) says almost a quarter (24%) of its eligible members cast votes in its 2017 Branch Committee Elections this year, with the record response an indication of the passion of the profession.
-
Diabetes webinar
Monday | May 15 2017AUSTRALIA and New Zealand's leading diabetes experts will be presenting in a webinar on 20 May focussing on clinical best practice and sharing the latest clinical evidence in diabetes care.
-
Chemo under dosing
Monday | May 15 2017THE Pharmacy Board of Australia has detailed part of the outcome of an investigation into chemotherapy under dosing at Royal Adelaide Hospital and Flinders Medical Centre, with probes of notifications about five pharmacists and four doctors now completed.
-
New insomnia Rx
Monday | May 15 2017MSD'S Belsomra, the first and only orexin receptor antagonist, which treats insomnia by reducing wakefulness and allowing sleep to take over, can now be prescribed and dispensed in Australia on a private prescription, with a pack of 30 tablets costing about $60.
-
Maxigesic progress
Monday | May 15 2017AN APPLICATION to the US Food and Drug Administration by AFT Pharmaceuticals for registration of Maxigesic tablets has been accepted, with the company saying it's a "significant milestone in getting Maxigesic into the key US market".
-
Global speakers connect
Monday | May 15 2017THE preview program for this year's Pharmacy Connect conference has been released, with a global line-up of international pharmacy speakers set to present.
-
Dispensary Corner 12 May 17
Friday | May 12 2017STRESSED; here's a great way to maintain mental health.
-
Eczema awareness
Friday | May 12 2017MAY is Eczema Awareness Month, with the Eczema Association of Australasia saying this years' campaign focuses on young people with the condition.
-
emla recommended
Friday | May 12 2017ASPEN Pharmacare's emla range was recommended by 98% of general practitioners recently polled about dermal anaesthesia.